Cardioprotective effect of L-arginine in myocardial ischemia and reperfusion in an isolated working rat heart model

Journal of Cardiovascular Surgery

Volumn 39, Issue 3, 1998, Pages 321-329

  Izhar, U ^a   Schwalb, H ^a   Borman, J B ^a   Merin, G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Arginine; Myocardial ischemia; Myocardial reperfusion; Nitric oxide

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGININE; CARDIOPLEGIC AGENT; LACTATE DEHYDROGENASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VASOACTIVE AGENT;

ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; CRYSTALLOID; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; NONHUMAN; OXYGEN CONSUMPTION; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ARGININE; CARDIOPLEGIC SOLUTIONS; ENZYME INHIBITORS; HEART; HEMODYNAMIC PROCESSES; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031848072     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
3. Moncada S. The L-arginine-nitric oxide pathway. Acta Physiol Scand 1992;145:201-27.
4. Weich G, Loscaizo J. Nitric oxide and the cardiovascular system. J Card Surg 1994;9:361-71.
5. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990;66:1561-75.
6. Dusting GJ. Nitric oxide in cardiovascular disorders. J Vasc Res 1995;32:143-61.
7. Lucchesi BR. Myocardial ischemia, reperfusion, and free radical injury. Am J Cardiol 1990;65:141-231.
8. Tsao PS, Aoki N, Lefer WJ, Johnson G, Lefer AM. Time course of endothelial ischemia and reperfusion in the cat. Circulation 1990;82:1402-12.
9. Van Benthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium - dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 1987;79:265-74.
10. Weyrich AS, Ma X-L, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-88.
11. Hiramatsu T, Forbess JM, Miura T, Mayer JE. Effect of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. J Thorac Cardiovasc Surg 1995;109:81-7.
12. Johnson G, Tsao PS, Lefer AM. Cardioprotective effect of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Car Med 1991;19:244-52.
13. Nakanishi K, Johansen JV, Lefer DJ. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992;263:H1650-8.
14. Nakanishi K, Zhao ZQ, Johanson JV. Blood cardioplegia enhanced with nitric oxide donors SPM-5185 counteracts post-ischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 1995;109:1146-54.
15. Hiramatsu T, Forbes JM, Miura T, Mayer JE. Effect of L-arginine cardioplegia in recovery of neonatal lamb hearts after 2 hours of cold ischemia. Ann Thorac Surg 1995;60:1187-92.
16. Engelman DT, Watanabe M, Engelman RM. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Cardiovasc Surg 1995;110:1047-53.
17. Neely JR, Liebermeister H, Battersby EJ, Morgen HE. Effect of pressure development on oxygen consumption by isolated rat hearts. Am J Physiol 1967;212:804-14.
18. Yamamoto F, Braimbridge MV, Hearse DJ. Calcium cardioplegia: the optimal calcium content for the St. Thomas' Hospital cardioplegia solution. J Cardiothorac Surg 1984;87:908-12.
19. Nelly JR, Rovetto MJ. Techniques for perfusing isolated rat hearts. Meth Enzymol 1975;39:43-60.
20. Schwalb H, Izhar U, Yaroslavsky E, Borman JB, Uretzky G. The effect of amino acids on the ischemic heart. Improvement of oxigenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation. J Thorac Cardiovasc Surg 1989;98:551-6.
21. Schwalb H, Kushnir T, Navon G, Yaroslavsky E, Borman JB, Uretzky G. The protective effect of enriched branched chain amino acid formulation in the ischemic heart: a phosphorous-31 nuclear magnetic resonance study. J Mol Cell Cardiol 1987; 19:991-8.
22. Bergmeyer HU, Bernt E, Hess B. Lactic dehydrogenase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. London: Academic Press 1963:736-43.
23. Lowery OH, Passonneau JV. A flexible system of enzymatic analysis. London: Academic Press 1972:123.
24. Lamprecht W, Stein P. Methods of enzymatic analysis. In: Bergmeyer HU, editor. London: Academic Press 1963:619.
25. Lefer AM, Tsao PS, Lefer DJ, Ma X-L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991;5:2029-34.
26. Amezcua JL, Palmer RMJ, Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates tone in the coronary circulation of the rabbit. Br J Pharmacol 1989;97:1119-24.
27. Siegfried MR, Erhardt J, Rider T, Ma X-L, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exper Ther 1992;260:668-75.
28. Fujita H, Yamabe H, Yano T. The effect of intravenously administrated L-arginine on myocardial perfusion abnormality in patients with microvascular angina (Abstract). J Am Coll Cardiol 1994;23:201A.
29. Macho P, Vanter SF. Effect of nitroglycerin and nitroprusside on large and small coronary vessels in conscious dogs. Circulation 1981;64:1101-7.
30. Kawata H, Aoki M, Mayer JE Jr. Nitroglycerin improved functional recovery of neonatal lamb hearts after 2 hours of cold ischemia. Circulation 1993;88(Suppl II):366-71.
31. Bath PMW, MacGregor N. Spontaneous nitric oxide donors inhibit monocyte chemotaxis and increase intracellular cGMP concentration. J Vasc Res 1992;29:170.
32. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 1986;320:454-6.
33. Rubanyi GM, Vanhoutte PM. Superoxide anion and hypoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-7.
34. Suzuki M, Inauen W, Kvietys PR. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interaction. Am J Physiol 1989;257:H1740-5.
35. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Paker-Botelho LH. Cytoprotective function of nitric oxide: inactivation of Superoxide radicals produced by human leukocyte. Biochem Biophys Res Comm 1991;181:1392-7.
36. Takeuchi K, Cao-Danh H, Glynn P, Simplaceanu E, McGowan FX, del-Nido PJ. Negative inotropic and metabolic effects of the nitric oxide precursors L-arginine: partial preservation by amiloride. Surg Forum 1993;44:264-6.
37. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-20.